CRISPR-Cas9-based gene editing of human mesenchymal stromal cells to improve the outcome of cell therapy
Event: ESC Congress 2020
Topic: Gene Therapy, Cell Therapy
Session: Basic Science Cardiac ePosters
ESC 365 is supported by
